Atlas Trials

Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis

Clinical trial NCT00423007 · COMPLETED

Trial details

NCT number
NCT00423007
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Start date
2006-11-01
Primary completion
2007-08-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.